October 24, 2017

SANOFI-AVENTIS U.S. LLC et al v. MYLAN N.V. et al

Track this case

Case Number:

3:17-cv-09105

Court:

New Jersey

Nature of Suit:

Patent - Abbreviated New Drug Application(ANDA)

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 26, 2017

    Sanofi Says Mylan Infringing 18 Insulin Patents

    Sanofi filed a patent infringement suit Tuesday in New Jersey federal court alleging Mylan's planned generic version of Sanofi's insulin pen, Lantus, infringes 18 of its patents.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!